Quick Answer
ANAPTYSBIO, INC reported Operating Income Loss of $47.90 million for the year ending 2025.
- ANAPTYSBIO, INC showed an increase of +141.7% in Operating Income Loss from 2024 to 2025.
- This data is from ANAPTYSBIO, INC's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), ANAPTYSBIO, INC's Operating Income Loss has grown by 1,541.8%.
- Historical annual values: Fiscal year 2025: $47.90 million | Fiscal year 2024: -$114.95 million | Fiscal year 2023: -$164.41 million | Fiscal year 2022: -$115.15 million | Fiscal year 2021: -$56.81 million | Fiscal year 2020: -$23.88 million | Fiscal year 2019: -$107.43 million | Fiscal year 2018: -$66.72 million | Fiscal year 2017: -$28.78 million | Fiscal year 2016: -$3.03 million | Fiscal year 2015: -$3.32 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: